N4 Pharma Plc (N4P.L)
GBp 0.53
(-8.7%)
GBp 0.53
(-8.7%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1953.00 | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | 1953.00 | - | - | - | - | - |
| Operating Expenses | 1.42 Million | 1.19 Million | 1.84 Million | 1.56 Million | 947.34 Thousand | 1.41 Million |
| Selling, General and Administrative Expenses | 717.98 Thousand | 615.73 Thousand | 663.86 Thousand | 664.01 Thousand | 730.39 Thousand | 643.74 Thousand |
| Research and Development Expenses | 619.39 Thousand | 577.52 Thousand | 1.17 Million | 900.41 Thousand | 216.94 Thousand | 846.17 Thousand |
| Other Expenses | 89.17 Thousand | - | - | - | - | -72.83 Thousand |
| Cost and Expenses | 1.42 Million | 1.19 Million | 1.84 Million | 1.56 Million | 947.34 Thousand | 1.41 Million |
| Operating Income | -1.42 Million | -1.19 Million | -1.84 Million | -1.56 Million | -947.34 Thousand | -1.41 Million |
| Interest Expense | - | 1.00 | - | 1963.00 | 1385.00 | 981.00 |
| Income Tax Expense | -147.81 Thousand | -163.99 Thousand | -298.26 Thousand | -261.54 Thousand | -72.35 Thousand | -205.53 Thousand |
| Earnings before Tax | -1.42 Million | -1.19 Million | -1.84 Million | -1.56 Million | -948.72 Thousand | -1.39 Million |
| Net Income | -1.26 Million | -1.02 Million | -1.54 Million | -1.3 Million | -876.37 Thousand | -1.18 Million |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Weighted Average Shares Outstanding | 242.88 Million | 186.42 Million | 181.08 Million | 136.3 Million | 100.16 Million | 89.44 Million |
| Weighted Average Shares Outstanding (Diluted) | 242.88 Million | 186.42 Million | 181.08 Million | 136.3 Million | 100.16 Million | 91.3 Million |
| Gross Margin | 1.00 | - | - | - | - | - |
| EBIT Margin | -683.78 | - | - | - | - | - |
| Profit Margin | -649.94 | - | - | - | - | - |
| EBITDA | -1.33 Million | -1.19 Million | -1.84 Million | -1.56 Million | -947.34 Thousand | -1.41 Million |
| Earnings Before Tax Margin | -729.44 | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 3906.00 | 1953.00 | 1953.00 | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | 3906.00 | 1953.00 | 1953.00 | - | - | - |
| Operating Expenses | 493.95 Thousand | 1.42 Million | 781.64 Thousand | 644.9 Thousand | 1.19 Million | 443.82 Thousand |
| Selling, General and Administrative Expenses | 379.92 Thousand | - | 354.87 Thousand | 452.27 Thousand | - | 277.71 Thousand |
| Research and Development Expenses | 114.03 Thousand | - | 426.76 Thousand | 192.63 Thousand | - | 166.1 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 493.95 Thousand | 1.42 Million | 781.64 Thousand | 644.9 Thousand | 1.19 Million | 443.82 Thousand |
| Operating Income | -490.04 Thousand | -1.42 Million | -779.69 Thousand | -644.91 Thousand | -1.19 Million | -443.82 Thousand |
| Interest Expense | - | - | - | - | 1.00 | - |
| Income Tax Expense | -36.83 Thousand | -147.81 Thousand | -147.81 Thousand | -122.08 Thousand | -163.99 Thousand | -163.99 Thousand |
| Earnings before Tax | -491.7 Thousand | -1.42 Million | -778.44 Thousand | -646.15 Thousand | -1.19 Million | -443.15 Thousand |
| Net Income | -454.86 Thousand | -1.26 Million | -623.18 Thousand | -646.15 Thousand | -1.02 Million | -279.15 Thousand |
| Earnings Per Share Basic | -0.00 | - | -0.00 | -0.00 | - | -0.00 |
| Earnings Per Share Diluted | -0.00 | - | -0.00 | -0.00 | - | -0.00 |
| Weighted Average Shares Outstanding | 285.39 Million | 242.88 Million | 253.11 Million | 233.78 Million | 186.42 Million | 233.78 Million |
| Weighted Average Shares Outstanding (Diluted) | 285.39 Million | 242.88 Million | 253.11 Million | 233.78 Million | 186.42 Million | 233.78 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | - | - | - |
| EBIT Margin | -125.89 | - | -399.23 | - | - | - |
| Profit Margin | -116.45 | -649.94 | -319.09 | - | - | - |
| EBITDA | -491.7 Thousand | - | -779.69 Thousand | -644.91 Thousand | - | -443.82 Thousand |
| Earnings Before Tax Margin | -125.46 | -729.44 | -399.23 | - | - | - |
BLACKROSE
001896
002148
STCK
AQUA
600644